Rheumatoid Arthritis Research - Rheumatoid Arthritis Clinical Trials
Rheumatoid arthritis research and clinical trials lead to better understanding of the disease. Researchers focus on finding the cause of rheumatoid arthritis. Researchers continue to search for a cure and develop better treatment options for rheumatoid arthritis.
Vitamin C and Arthritis: Opposite Findings for OA and RA
Two studies have opposite findings regarding the relationship between vitamin C and arthritis.
Two studies have opposite findings regarding the relationship between vitamin C and arthritis.
Risk Of RA May Be Tied To Birth Weight
A new study in the British Medical Journal concludes that birth weight may be a factor in the risk of developing rheumatoid arthritis.
A new study in the British Medical Journal concludes that birth weight may be a factor in the risk of developing rheumatoid arthritis.
Rituxan Shows Sustained Benefit For RA In Phase II Trials
Results from Phase II clinical trials for Rituxan were announced by Genentech, IDEC Pharmaceuticals, and Roche, at the 2003 American College of Rheumatology meeting in Orlando, Florida. The news is encouraging.
Results from Phase II clinical trials for Rituxan were announced by Genentech, IDEC Pharmaceuticals, and Roche, at the 2003 American College of Rheumatology meeting in Orlando, Florida. The news is encouraging.
Chemo/Stem Cell Experiment Helps RA
Two years following a stem cell transplant from his healthy identical twin, an RA patient is no longer exhibiting any arthritic symptoms.
Two years following a stem cell transplant from his healthy identical twin, an RA patient is no longer exhibiting any arthritic symptoms.
Rheumatoid Arthritis Does Not Increase Lung Cancer Risk
Rheumatoid arthritis does not increase the risk of lung cancer, according to new research. Previous research showed an increased risk but could not assign causality because of lack of data.
Rheumatoid arthritis does not increase the risk of lung cancer, according to new research. Previous research showed an increased risk but could not assign causality because of lack of data.
Rituxan: Showing Promise For Rheumatoid Arthritis
Rituxan, a drug used to target B-cells, is showing promise as a treatment for rheumatoid arthritis.
Rituxan, a drug used to target B-cells, is showing promise as a treatment for rheumatoid arthritis.
Clinical Trials - Why Volunteer?
"Clinical trial" is the scientific term for a test or study of a drug or medical device in people. These tests are done to see if the drug or device is safe and effective for people to use. Doctors and other health professionals run the tests according to strict rules set by the Food and Drug Administration (FDA).
"Clinical trial" is the scientific term for a test or study of a drug or medical device in people. These tests are done to see if the drug or device is safe and effective for people to use. Doctors and other health professionals run the tests according to strict rules set by the Food and Drug Administration (FDA).
Rheumatoid Arthritis Treatments Do Not Increase Breast Cancer Risk
Research shows no evidence to date that rheumatoid arthritis treatments, particularly the newest medications, increases the risk of breast cancer.
Research shows no evidence to date that rheumatoid arthritis treatments, particularly the newest medications, increases the risk of breast cancer.
What is the ACR Criteria? What Does ACR Criteria Indicate?
The improvement in rheumatoid arthritis patients is judged using ACR criteria during clinical trials. ACR criteria is expressed as ACR 20, ACR 50, ACR 70.
The improvement in rheumatoid arthritis patients is judged using ACR criteria during clinical trials. ACR criteria is expressed as ACR 20, ACR 50, ACR 70.
National Databank For Rheumatic Diseases: Rheumatoid Arthritis
The National Databank for Rheumatic Diseases is a research databank for the study of arthritis and rheumatic conditions. If you have been diagnosed with Rheumatoid Arthritis, you are eligible to participate in NDB research.
The National Databank for Rheumatic Diseases is a research databank for the study of arthritis and rheumatic conditions. If you have been diagnosed with Rheumatoid Arthritis, you are eligible to participate in NDB research.
Subscribe To Our Free Weekly Newsletter
Let us keep you informed with the latest in arthritis. Subscribe to our free weekly newsletter.
Let us keep you informed with the latest in arthritis. Subscribe to our free weekly newsletter.
Rituxan: Showing Promise For Rheumatoid Arthritis
Rituxan, a drug used to target B-cells, is showing promise as a treatment for rheumatoid arthritis.
Rituxan, a drug used to target B-cells, is showing promise as a treatment for rheumatoid arthritis.
The Blog News Archive
Check out our Blog News Archive for the latest news related to arthritis.
Check out our Blog News Archive for the latest news related to arthritis.
Rheumatoid Arthritis Screening Quiz
Do you have symptoms associated with rheumatoid arthritis?
Do you have symptoms associated with rheumatoid arthritis?
Clinical Trials: Rheumatoid Arthritis
Clinical trials for Rheumatoid Arthritis, from ClinicalTrials.gov.
Clinical trials for Rheumatoid Arthritis, from ClinicalTrials.gov.
Clinical Trials: Rheumatoid Arthritis
Clinical trials for rheumatoid arthritis, from CenterWatch.
Clinical trials for rheumatoid arthritis, from CenterWatch.